Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?
Authors
Keywords
-
Journal
Gut Pathogens
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-26
DOI
10.1186/s13099-021-00407-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence of Clostridioides difficile and Other Gastrointestinal Pathogens in Patients with COVID-19
- (2021) Monika Laszkowska et al. DIGESTIVE DISEASES AND SCIENCES
- Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
- (2021) Yun Kit Yeoh et al. GUT
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks
- (2020) Raphaël Enaud et al. Frontiers in Cellular and Infection Microbiology
- Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
- (2020) Rong-Hui Du et al. EUROPEAN RESPIRATORY JOURNAL
- Associations between Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality among Patients with COVID-19
- (2020) Nian-Di Tan et al. GASTROENTEROLOGY
- Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
- (2020) Tao Zuo et al. GASTROENTEROLOGY
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ringing bells: Morganella morganii fights for recognition
- (2020) Altaf Bandy PUBLIC HEALTH
- SARS-CoV-2 receptor ACE2 gene expression in small intestine correlates with age
- (2020) Raphael N. Vuille-dit-Bille et al. AMINO ACIDS
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
- (2020) Víctor J. Costela-Ruiz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19
- (2020) Tao Zuo et al. GUT
- Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome
- (2020) Loris Roncon et al. JOURNAL OF CLINICAL VIROLOGY
- Gut microbiota and Covid-19- possible link and implications
- (2020) Debojyoti Dhar et al. VIRUS RESEARCH
- COVID-19 and the Gut Microbiome: More than a Gut Feeling
- (2020) Daniel van der Lelie et al. mSystems
- Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity
- (2020) Lingling Tang et al. Engineering
- Enteric involvement in hospitalised patients with COVID-19 outside Wuhan
- (2020) Yunle Wan et al. Lancet Gastroenterology & Hepatology
- Managing the Inevitable Surge of Post–COVID-19 Functional Gastrointestinal Disorders
- (2020) Max Schmulson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Probiotics in the prophylaxis of COVID-19: something is better than nothing
- (2020) Kushal Gohil et al. 3 Biotech
- A cross talk between dysbiosis and gut-associated immune system governs the development of inflammatory arthropathies
- (2019) Alexander Kalinkovich et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Analysis of microbiota in elderly patients with Acute Cerebral Infarction
- (2019) Lin Huang et al. PeerJ
- The gut microbiome: Relationships with disease and opportunities for therapy
- (2018) Juliana Durack et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR4 deficiency reduces pulmonary resistance to Streptococcus pneumoniae in gut microbiota-disrupted mice
- (2018) Hongyan Wang et al. PLoS One
- The role of the microbiota in infectious diseases
- (2018) Josie Libertucci et al. Nature Microbiology
- A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs
- (2016) Brittan S. Scales et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The gut microbiota and inflammatory noncommunicable diseases: Associations and potentials for gut microbiota therapies
- (2015) Christina E. West et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Role of the Microbiota in Immunity and Inflammation
- (2014) Yasmine Belkaid et al. CELL
- Effects of Consumption of a Fermented Dairy Product Containing the Probiotic Lactobacillus casei DN-114 001 on Common Respiratory and Gastrointestinal Infections in Shift Workers in a Randomized Controlled Trial
- (2013) Eric Guillemard et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation
- (2012) Tatsuo Hashimoto et al. NATURE
- Probiotic Prophylaxis of Ventilator-associated Pneumonia
- (2010) Lee E. Morrow et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
- (2009) G. Y. Oudit et al. DIABETES
- Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2
- (2009) Jan Wysocki et al. HYPERTENSION
- Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2 Activators as Novel Antihypertensive Agents
- (2008) José A. Hernández Prada et al. HYPERTENSION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More